164 related articles for article (PubMed ID: 23868481)
1. Clinical costs of colorectal cancer screening in 5 federally funded demonstration programs.
Tangka FK; Subramanian S; Beebe MC; Hoover S; Royalty J; Seeff LC
Cancer; 2013 Aug; 119 Suppl 15(0 15):2863-9. PubMed ID: 23868481
[TBL] [Abstract][Full Text] [Related]
2. Costs of planning and implementing the CDC's Colorectal Cancer Screening Demonstration Program.
Subramanian S; Tangka FK; Hoover S; Beebe MC; DeGroff A; Royalty J; Seeff LC
Cancer; 2013 Aug; 119 Suppl 15(Suppl 15):2855-62. PubMed ID: 23868480
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.
Seeff LC; Royalty J; Helsel WE; Kammerer WG; Boehm JE; Dwyer DM; Howe WR; Joseph D; Lane DS; Laughlin M; Leypoldt M; Marroulis SC; Mattingly CA; Nadel MR; Phillips-Angeles E; Rockwell TJ; Ryerson AB; Tangka FK
Cancer; 2013 Aug; 119 Suppl 15():2820-33. PubMed ID: 23868476
[TBL] [Abstract][Full Text] [Related]
4. Costs of colorectal cancer screening provision in CDC's Colorectal Cancer Control Program: Comparisons of colonoscopy and FOBT/FIT based screening.
Subramanian S; Tangka FKL; Hoover S; Royalty J; DeGroff A; Joseph D
Eval Program Plann; 2017 Jun; 62():73-80. PubMed ID: 28190597
[TBL] [Abstract][Full Text] [Related]
5. Clinical and programmatic costs of implementing colorectal cancer screening: evaluation of five programs.
Subramanian S; Tangka FK; Hoover S; Degroff A; Royalty J; Seeff LC
Eval Program Plann; 2011 May; 34(2):147-53. PubMed ID: 21036399
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Program Resources Required for Colonoscopy and Fecal Screening: Findings From 5 Years of the Colorectal Cancer Control Program.
Subramanian S; Tangka FKL; Hoover S; Cole-Beebe M; Joseph D; DeGroff A
Prev Chronic Dis; 2019 Apr; 16():E50. PubMed ID: 31022371
[TBL] [Abstract][Full Text] [Related]
7. Assessing screening quality in the CDC's Colorectal Cancer Screening Demonstration Program.
Nadel MR; Royalty J; Shapiro JA; Joseph D; Seeff LC; Lane DS; Dwyer DM
Cancer; 2013 Aug; 119 Suppl 15(0 15):2834-41. PubMed ID: 23868477
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
Sharaf RN; Ladabaum U
Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
[TBL] [Abstract][Full Text] [Related]
9. Moving forward: using the experience of the CDCs' Colorectal Cancer Screening Demonstration Program to guide future colorectal cancer programming efforts.
Seeff LC; DeGroff A; Joseph DA; Royalty J; Tangka FK; Nadel MR; Plescia M
Cancer; 2013 Aug; 119 Suppl 15():2940-6. PubMed ID: 23868488
[TBL] [Abstract][Full Text] [Related]
10. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.
Lansdorp-Vogelaar I; van Ballegooijen M; Zauber AG; Habbema JD; Kuipers EJ
J Natl Cancer Inst; 2009 Oct; 101(20):1412-22. PubMed ID: 19779203
[TBL] [Abstract][Full Text] [Related]
11. Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare.
Ladabaum U; Mannalithara A; Brill JV; Levin Z; Bundorf KM
Am J Gastroenterol; 2018 Dec; 113(12):1836-1847. PubMed ID: 29904156
[TBL] [Abstract][Full Text] [Related]
12. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals.
Ladabaum U; Mannalithara A; Jandorf L; Itzkowitz SH
Cancer; 2015 Apr; 121(7):1088-97. PubMed ID: 25492455
[TBL] [Abstract][Full Text] [Related]
14. Recruiting patients into the CDC's Colorectal Cancer Screening Demonstration Program: strategies and challenges across 5 sites.
Boehm JE; Rohan EA; Preissle J; DeGroff A; Glover-Kudon R
Cancer; 2013 Aug; 119 Suppl 15(0 15):2914-25. PubMed ID: 23868486
[TBL] [Abstract][Full Text] [Related]
15. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
Phisalprapa P; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
[No Abstract] [Full Text] [Related]
18. Budget Impact Analysis of Against Colorectal Cancer In Our Neighborhoods (ACCION): A Successful Community-Based Colorectal Cancer Screening Program for a Medically Underserved Minority Population.
Kim B; Lairson DR; Chung TH; Kim J; Shokar NK
Value Health; 2017 Jun; 20(6):809-818. PubMed ID: 28577699
[TBL] [Abstract][Full Text] [Related]
19. Clinical case management and navigation for colonoscopy screening in an academic medical center.
Cavanagh MF; Lane DS; Messina CR; Anderson JC
Cancer; 2013 Aug; 119 Suppl 15():2894-904. PubMed ID: 23868484
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of screening for colorectal cancer in the general population.
Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
